Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.

about

Nrf2: not "lost in translation".A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma

P2860

Q42327731-286BE9EF-CA71-4493-99D5-B2D2AE7C7A73 Q58776948-7D6D2478-6A62-4BA0-9968-198330DBC1B5

P2860

Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.

Item

http://www.wikidata.org/entity/Q38818674

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.

@en

type

Item

label

Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.

@en

prefLabel

Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.

@en

P1476

Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.

@en

P2093

Erica Campagnaro

http://www.w3.org/2001/XMLSchema#string

Tanya M Wildes

http://www.w3.org/2001/XMLSchema#string

P2860

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials.

Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.

Hematopoietic stem cell transplantation for hematologic malignancies in older adults: geriatric principles in the transplant clinic.

Ability of older people with dementia or cognitive impairment to manage medicine regimens: a narrative review

Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials.

The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma

Factors that influence health-related quality of life in newly diagnosed patients with multiple myeloma aged ≥ 65 years treated with melphalan, prednisone and lenalidomide followed by lenalidomide maintenance: results of a randomized trial.

International staging system for multiple myeloma.

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JGO.2016.04.001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27118356

http://www.w3.org/2001/XMLSchema#string

P932

5075272

http://www.w3.org/2001/XMLSchema#string

Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.

about

P2860

P2860

Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932